Trump’s family could reap major rewards from his ‘TrumpRx’ plan

Screenshot from the video: “Trump makes an announcement” by The Associated Press. Article by Ja’han Jones. MSNBC – October 10, 2025.

The president’s family is poised to take advantage of the drug market that he’s attempting to open up. No, this isn’t the plot of some kingpin drama on Starz. Rather, it’s the conclusion of new reporting from The Wall Street Journal on how a business tied to Donald Trump Jr. stands to benefit from his father’s newly announced plan to launch a Trump-branded pharmaceutical market funded by the government. To be clear, we’re talking about legal pharmaceuticals. […]

Click here to view original web page at www.msnbc.com

Video: Trump makes an announcement – The Associated Press

Related articles:

Trump unveils deal for AstraZeneca to cut Medicaid drug prices and join “TrumpRx” site – CBS News

GoodRx Wants In on Direct-to-Consumer TrumpRx Platform – BioSpace

AstraZeneca Joins Trump’s Push to Make Medicines Cheaper — But Why Are Critics Skeptical? – International Business Times

Watchdog: Trump Scrapped Serious Efforts to Lower Rx Drug Prices, Now Pushing “Direct-to-Consumer” Scheme That Won’t Save Patients Much…But Will Enrich His Son – Accountable.US